Trellis Bioscience, Inc.
2-B Corporate Drive
South San Francisco, CA 94080
tel 650.616.1100

Directions to Trellis Bioscience

Board Of Directors

James Broderick, MD, Chairman of the Board, joined Morgenthaler Ventures in 1998 and is a partner focused on investments in the life sciences industry. Trained as a physician and an engineer, Jim holds a BS in mechanical engineering from MIT and an MD from the University of Massachusetts. He is a Kauffman Fellow and previously worked as a consultant at Mercer Management Consulting and as a resident at Duke University Medical Center.

John Friedman is the founder of Easton Capital Investment Group which manages $200 million in venture capital and private equity funds. Prior, he founded and was Managing General Partner of Security Pacific Capital Investors. He has been Managing Director and Partner at E. M. Warburg, Pincus & Co., was an attorney at Sullivan and Cromwell and coChairs the Cold Spring Harbor Laboratory President's Council. He holds a JD degree from Yale Law School and a BA degree from Yale College.

Markus Goebel, MD, PhD, is Managing Director of the Novartis Venture Fund. Dr. Goebel was Novartis' Head of Pharma Corporate M&A and Nervous System Business Development and Licensing prior to joining the Fund. He has held several positions in R&D, Marketing and Strategy at Roche headquarters before joining Novartis. Dr Goebel received an MD and a PhD from the Ludwig Maximilian's University in Munich and an MBA from Henley Management College.

Stote Ellsworth, President and Chief Technology Officer, has spent his career bringing high technology systems solutions to the life science industry. He joined Trellis in 2003 to bring to reality the company’s CellSpot™ platform now responsible for generating a pipeline of totally human therapeutic antibodies directly from human blood. The platform blends life science technology in cell and molecular biology with state-of-the-art microscopy, software, and nanotechnology. Prior to Trellis, Mr. Ellsworth was the VP R&D and Chief Operating Officer at First Medical, a point-of-care cardiac diagnostic company acquired by Sigma in 2000. This was preceded by a role as Vice President of Engineering at Becton Dickinson where he was responsible for developing through commercial release numerous flow cytometry products which now dominate that market. He holds a degree in Bioscience Technology from the University of California Santa Cruz, a BA from Dartmouth in Engineering and Mathematics, and an MS in Electrical Engineering from Stanford University.

Lawrence Kauvar, PhD, Founder and Senior Vice President, is an entrepreneur and scientist who founded Trellis and was previously the founder and CSO of Telik. He holds 40 US patents for methods, tools and drug compounds and is one of the inventors of CellSpot™, Trellis' core technology. Dr. Kauvar holds a PhD from Yale in Molecular Biophysics and Biochemistry, did his post doctoral studies at Caltech and holds an undergraduate degree from Harvard.

Jerry McMahon, PhD, was appointed Chief Executive Officer of Poniard in May 2004 and Chairman of the Board of Directors in June 2004. Previously, he was President of SUGEN, Inc., a biopharmaceutical company focused on the discovery and development of novel, targeted small-molecule drugs. Dr. McMahon played a key role in the discovery and development of Sutent® and Palladia®, which are protein kinase products for the treatment of advanced cancers, currently marketed by Pfizer. He joined SUGEN in 1993 and, following the acquisition of SUGEN by Pharmacia in 1999, Dr. McMahon served as a key executive in the management of R&D at Pharmacia, and as President of SUGEN until the acquisition of Pharmacia by Pfizer in 2003. Prior to SUGEN, Dr. McMahon held management positions from 1988 to 2003 at Sandoz Pharmaceuticals, Inc in East Hanover, New Jersey. Dr. McMahon holds a B.S. in biology and a Ph.D. in 1980 in biochemistry from Rensselaer Polytechnic Institute and held post-graduate appointments at Tufts Medical School in Boston and the Massachusetts Institute of Technology in Cambridge, Massachusetts.